Variantyx

Advanced Genomic Diagnostic Solutions

Health Tech & Life Sciences
Active
Series D Tel Aviv-Yafo, Israel Founded 2014
Last updated 2026-06-18
Total raised
$131.5M
Last: 2025-04
Stage
Series D
Founded
2014
Headcount
215
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Variantyx is an award-winning, technology-driven molecular diagnostics lab that offers innovative solutions in the genetic disorders, reproductive health, and precision oncology markets. Its proprietary whole genome analysis platform provides unparalleled diagnostic capabilities, enhances personalized treatment recommendations, shortens the time to diagnosis, and reduces healthcare costs.

The company offers a wide variety of test options, ranging from targeted to comprehensive analyses. Targeted analyses focus on pre-curated panels of indication-relevant genes while comprehensive analyses consider all genes. All tests are performed on a whole genome platform. This makes it easy to start with a targeted analysis and automatically reflex up to a comprehensive analysis if the first test is non-diagnostic. No additional sample or sequencing is required.

Funding history · 10 rounds · $131.5M total

Q&A

What is Variantyx's primary focus?
Variantyx is a technology-driven molecular diagnostics lab that provides advanced genomic diagnostic solutions in genetic disorders, reproductive health, and precision oncology markets.
When was Variantyx founded?
Variantyx was founded in May 2014.
What is the total amount of funding Variantyx has raised to date?
Variantyx has raised a total of $131.5 million USD.
Which investors participated in Variantyx's funding round in April 2024?
In April 2024, Variantyx received funding from Peregrine Ventures, Robert Bosch Venture Capital, Pitango HealthTech, and New Era Capital Partners.
Which investor participated in Variantyx's funding round in October 2022?
In October 2022, Variantyx received $20 million USD in funding from Kreos Capital.
How many employees does Variantyx currently have?
Variantyx has 201-500 employees.
Who are the co-founders of Variantyx?
The co-founders of Variantyx are Haim Neerman (Co-founder & CEO), Noam Shomron (Co-founder & CSO), and Tomer Jackman (Co-founder & VP Customer Support and Lab Services).
Where is Variantyx's headquarters located?
Variantyx's headquarters is located in Tel Aviv-Yafo, Israel.
What is Variantyx's current funding stage?
Variantyx is currently in its Series D funding stage.

Team · 3

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CSO
LinkedIn ↗
Founder · Co-founder & VP Customer Support and Lab Services
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Platforms & InterfacesSoftwareArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersLaboratoriesConsumersDemographics & FamilyWomen
Business model
B2BB2B2C

Highlights

1 PatentsVerified

Tags

biopharmaceuticalpharma-companiespersonalizationprecision-medicineoncologynon-invasivepregnancypersonalized-medicinecancerclinical-datamedical-technologiesgenetic-disordershospitalsgenomicsdoctorsclinicslaboratoriesdiagnosticswomen-healthrare-diseasesdigital-healthcareartificial-intelligence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitevariantyx.com
LinkedInlinkedin.com/company/5378447
Facebookfacebook.com/Variantyx

Identifiers & details

Founded2014-5
Employees (exact)215
OfficesFramingham

Radar intelligence

Publications (Crossref)

Works10

GitHub

Top reposstatic

Web history (Wayback)

Domainvariantyx.com

Certificate / subdomain footprint

Subdomains27